Cipla to acquire majority stake in UAE-based pharma manufacturer for $21M
Mumbai-based drugmaker Cipla Ltd is acquiring 51 per cent stake in a UAE-based pharmaceutical company which has manufacturing and distribution business in Yemen for $21 million.
“Given the recent preference to local manufacturing, this secures the company’s presence in a fast growing market,” the company said in a stock exchange announcement.
At present Cipla has over 200 products in Yemen market. The company will pay $21.... Read more »
Posted on : Monday , 28th July 2014